DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02652 CF PHARMTECH

Trading Add to Porfolio
Index Constituent : None
Major Shareholders LIANG Bill Wenqing (15.22%)
Future Industry Investment Fund (Limited Partnership) (6.33%)
LI LI BOVET (5.82%)		 Sector Health Care & Biotechnology
Web Site http://www.cfpharmtech.com Tel (86 512) 6618-8089
Email ir@cfpharmtech.comir@cfpharmtech.com Fax N/A
Related Equities N/A
Principal Activities Mainly engaged in the research and development of respiratory drugs and other related medical products.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top